Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement


On 2 September, Agilent Technologies Inc. announced the signing of a worldwide distribution agreement with  Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software in addition to Agilent’s portfolio of automated pathology staining solutions.

Read more about this news here.

Related articles

Recent articles